Search research articles
Contact Us
Filters
Showing results (701-710 of 1,834) with videos related to
Page
of 184
Sort By:
Mabs
|
November 21, 2013
Monoclonal anti-β1-adrenergic receptor antibodies activate G protein signaling in the absence of β-arrestin recruitment
Catherine J Hutchings, Gabriella Cseke, Greg Osborne, et al.
Mabs
|
July 26, 2013
Purification of monoclonal antibodies by hydrophobic interaction chromatography under no-salt conditions
Sanchayita Ghose, Yinying Tao, Lynn Conley, et al.
Mabs
|
December 19, 2012
Structural analysis of a therapeutic monoclonal antibody dimer by hydroxyl radical footprinting
Galahad Deperalta, Melissa Alvarez, Charity Bechtel, et al.
Mabs
|
December 21, 2012
American Association of Pharmaceutical Scientists National Biotechnology Conference Short Course: Translational Challenges in Developing Antibody-Drug Conjugates: May 24, 2012, San Diego, CA
Karen Thudium, Sanela Bilic, Douglas Leipold, et al.
Mabs
|
December 6, 2012
Approaches to improve tumor accumulation and interactions between monoclonal antibodies and immune cells
Fabrizio Marcucci, Matteo Bellone, Cristiano Rumio, et al.
Mabs
|
December 11, 2012
Conformational characterization of the charge variants of a human IgG1 monoclonal antibody using H/D exchange mass spectrometry
Liangjie Tang, Shanmuuga Sundaram, Jingming Zhang, et al.
Mabs
|
June 12, 2012
7th cancer scientific forum of theCancéropôle Lyon Auvergne Rhône-Alpes: March 20-21, 2012, Lyon, France
Petrus J Pauwels, Charles Dumontet, Janice M Reichert, et al.
Mabs
|
June 1, 2012
Expression and biological characterization of an anti-CD20 biosimilar candidate antibody: a case study
Denise Dorvignit, Julio L Palacios, Maylin Merino, et al.
Mabs
|
August 9, 2013
Affinity-matured recombinant immunotoxin targeting gangliosides 3'-isoLM1 and 3',6'-isoLD1 on malignant gliomas
Hailan Piao, Chien-Tsun Kuan, Vidya Chandramohan, et al.
Mabs
|
August 9, 2013
Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques
Daniel Ayoub, Wolfgang Jabs, Anja Resemann, et al.
Page
of 184
Search research articles
Search
Showing results (701-710 of 1,834) with videos related to
Sort By:
Page
of 184
Mabs
|
November 21, 2013
Monoclonal anti-β1-adrenergic receptor antibodies activate G protein signaling in the absence of β-arrestin recruitment
Catherine J Hutchings, Gabriella Cseke, Greg Osborne, et al.
Mabs
|
July 26, 2013
Purification of monoclonal antibodies by hydrophobic interaction chromatography under no-salt conditions
Sanchayita Ghose, Yinying Tao, Lynn Conley, et al.
Mabs
|
December 19, 2012
Structural analysis of a therapeutic monoclonal antibody dimer by hydroxyl radical footprinting
Galahad Deperalta, Melissa Alvarez, Charity Bechtel, et al.
Mabs
|
December 21, 2012
American Association of Pharmaceutical Scientists National Biotechnology Conference Short Course: Translational Challenges in Developing Antibody-Drug Conjugates: May 24, 2012, San Diego, CA
Karen Thudium, Sanela Bilic, Douglas Leipold, et al.
Mabs
|
December 6, 2012
Approaches to improve tumor accumulation and interactions between monoclonal antibodies and immune cells
Fabrizio Marcucci, Matteo Bellone, Cristiano Rumio, et al.
Mabs
|
December 11, 2012
Conformational characterization of the charge variants of a human IgG1 monoclonal antibody using H/D exchange mass spectrometry
Liangjie Tang, Shanmuuga Sundaram, Jingming Zhang, et al.
Mabs
|
June 12, 2012
7th cancer scientific forum of theCancéropôle Lyon Auvergne Rhône-Alpes: March 20-21, 2012, Lyon, France
Petrus J Pauwels, Charles Dumontet, Janice M Reichert, et al.
Mabs
|
June 1, 2012
Expression and biological characterization of an anti-CD20 biosimilar candidate antibody: a case study
Denise Dorvignit, Julio L Palacios, Maylin Merino, et al.
Mabs
|
August 9, 2013
Affinity-matured recombinant immunotoxin targeting gangliosides 3'-isoLM1 and 3',6'-isoLD1 on malignant gliomas
Hailan Piao, Chien-Tsun Kuan, Vidya Chandramohan, et al.
Mabs
|
August 9, 2013
Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques
Daniel Ayoub, Wolfgang Jabs, Anja Resemann, et al.
Page
of 184